|
業務類別
|
Biotechnology |
|
業務概覽
|
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic. |
| 公司地址
| 2445 Technology Forest Boulevard, 11th Floor, The Woodlands, TX, USA, 77381 |
| 電話號碼
| +1 281 863-3000 |
| 傳真號碼
| +1 281 863-8088 |
| 公司網頁
| https://www.lexpharma.com |
| 員工數量
| 81 |
| Dr. Michael Exton, PhD |
Chief Executive Officer and Director |
美元 650.58K |
16/03/2026 |
| Mr. Scott M. Coiante |
Senior Vice President and Chief Financial Officer |
美元 444.17K |
05/03/2026 |
| Ms. Rachel Yap Martens |
Senior Vice President, Partnerships and Corporate Strategy |
-- |
05/03/2026 |
| Mr. Brian T. Crum |
Senior Vice President and General Counsel |
美元 489.93K |
05/03/2026 |
| Ms. Lisa DeFrancesco |
Senior Vice President, Investor Relations and Corporate Communications |
-- |
05/03/2026 |
| Ms. Suma Gopinathan, M.S.,PhD |
Senior Vice President, Discovery |
-- |
05/03/2026 |
| Ms. Kristen L. Alexander |
Vice President, Finance and Accounting and Principal Accounting Officer |
-- |
02/01/2025 |
| Dr. Craig B. Granowitz, M.D.,PhD |
Senior Vice President and Chief Medical Officer |
美元 519.34K |
05/03/2026 |
| Ms. Wendy E. McDermott |
Senior Vice President, Human Resources |
美元 415.76K |
05/03/2026 |
|
|
| Dr. Michael Exton, PhD |
Chief Executive Officer and Director |
16/03/2026 |
| Ms. Diane E. Sullivan |
Independent Director |
16/03/2026 |
| Mr. Raymond Debbane |
Chairman of the Board |
16/03/2026 |
| Dr. Samuel L. Barker,PhD |
Independent Director |
16/03/2026 |
| Mr. Christopher J. Sobecki |
Independent Director |
16/03/2026 |
| Mr. Philippe J. Amouyal |
Independent Director |
16/03/2026 |
| Dr. Judith L. Swain,M.D. |
Independent Director |
16/03/2026 |
| Mr. Ivan H. Cheung |
Independent Director |
16/03/2026 |
|
|
|
|
